down arrow

Tejnaksh Health.

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE030T01027
  • NSEID:
  • BSEID: 539428
INR
23.28
1.45 (6.64%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 2.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.18 k (-50.70%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

73.83%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -4.66% CAGR growth in Operating Profits over the last 5 years

  • The company has been able to generate a Return on Equity (avg) of 9.75% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 47 Cr (Micro Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

9.24%

stock-summary
Price to Book

1.79

Revenue and Profits (1 Year):
Net Sales:
3 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-9.45%
0%
-9.45%
1 Year
-7.69%
0%
-7.69%
2 Years
-41.95%
0%
-41.95%
3 Years
-71.74%
0%
-71.74%
4 Years
-34.1%
0%
-34.1%
5 Years
27.91%
0%
27.91%

Tejnaksh Health. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-7.22%
EBIT Growth (5y)
-4.66%
EBIT to Interest (avg)
3.07
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.52
Tax Ratio
29.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.56%
ROE (avg)
9.75%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
55
Price to Book Value
1.79
EV to EBIT
13.78
EV to EBITDA
10.65
EV to Capital Employed
1.75
EV to Sales
3.61
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
12.38%
ROE (Latest)
9.24%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ashish Vishwas Rawandale (38.15%)

Highest Public shareholder

Sheetal Utkarsh Rawandale (1.45%)

Individual Investors Holdings

23.65%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 1.59% vs 17.60% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 3.70% vs 74.19% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.19",
          "val2": "3.14",
          "chgp": "1.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.13",
          "val2": "1.07",
          "chgp": "5.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.14",
          "val2": "0.19",
          "chgp": "-26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.56",
          "val2": "0.54",
          "chgp": "3.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.42%",
          "val2": "34.08%",
          "chgp": "1.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 6.05% vs -4.52% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 63.51% vs -47.14% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.49",
          "val2": "6.12",
          "chgp": "6.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.22",
          "val2": "1.65",
          "chgp": "34.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.22",
          "val2": "0.32",
          "chgp": "-31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.21",
          "val2": "0.74",
          "chgp": "63.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.21%",
          "val2": "26.96%",
          "chgp": "7.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 4.54% vs 1.98% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 38.28% vs -25.15% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.68",
          "val2": "9.26",
          "chgp": "4.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.35",
          "val2": "2.72",
          "chgp": "23.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.51",
          "chgp": "-29.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.77",
          "val2": "1.28",
          "chgp": "38.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.61%",
          "val2": "29.37%",
          "chgp": "5.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.84% vs -7.49% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 4.76% vs -38.24% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.18",
          "val2": "11.73",
          "chgp": "3.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.63",
          "val2": "3.69",
          "chgp": "-1.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.64",
          "val2": "0.61",
          "chgp": "4.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.76",
          "val2": "1.68",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.80%",
          "val2": "31.46%",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3.19
3.14
1.59%
Operating Profit (PBDIT) excl Other Income
1.13
1.07
5.61%
Interest
0.14
0.19
-26.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.56
0.54
3.70%
Operating Profit Margin (Excl OI)
35.42%
34.08%
1.34%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 1.59% vs 17.60% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 3.70% vs 74.19% in Dec 2023

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
6.49
6.12
6.05%
Operating Profit (PBDIT) excl Other Income
2.22
1.65
34.55%
Interest
0.22
0.32
-31.25%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.21
0.74
63.51%
Operating Profit Margin (Excl OI)
34.21%
26.96%
7.25%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 6.05% vs -4.52% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 63.51% vs -47.14% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
9.68
9.26
4.54%
Operating Profit (PBDIT) excl Other Income
3.35
2.72
23.16%
Interest
0.36
0.51
-29.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.77
1.28
38.28%
Operating Profit Margin (Excl OI)
34.61%
29.37%
5.24%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 4.54% vs 1.98% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 38.28% vs -25.15% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
12.18
11.73
3.84%
Operating Profit (PBDIT) excl Other Income
3.63
3.69
-1.63%
Interest
0.64
0.61
4.92%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.76
1.68
4.76%
Operating Profit Margin (Excl OI)
29.80%
31.46%
-1.66%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 3.84% vs -7.49% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 4.76% vs -38.24% in Mar 2023

stock-summaryCompany CV
About Tejnaksh Healthcare Ltd stock-summary
stock-summary
Tejnaksh Healthcare Ltd
Micro Cap
Hospital & Healthcare Services
Tejnaksh Healthcare Limited was incorporated in Mumbai as "Tejnaksh Healthcare Private Limited" on 18 February, 2008 as a Private Limited Company. Company was converted to a Public Limited Company and the name was changed to "Tejnaksh Healthcare Limited" vide fresh Certificate of Incorporation dated 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.
Company Coordinates stock-summary
Company Details
A 601 Floor No 6 Kailash, Business Park Veer SavarkarMar Mumbai Maharashtra : 400079
stock-summary
Tel:
stock-summary
cs.tejnaksh@gmail.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai